Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in Older Adults

• Autores: Jake Scott, Matthew Bidwell Goetz
• Localización: Clinics in geriatric medicine, ISSN 0749-0690, Vol. 32, Nº. 3, 2016, págs. 571-583
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Improved survival with combination antiretroviral therapy has led to a dramatic increase in the number of human immunodeficiency virus (HIV)–infected individuals 50 years of age or older such that by 2020 more than 50% of HIV-infected persons in the United States will be above this age. Recent studies confirm that antiretroviral therapy should be offered to all HIV-infected patients regardless of age, symptoms, CD4+ cell count, or HIV viral load. However, when compared with HIV-uninfected populations, even with suppression of measurable HIV replication, older individuals are at greater risk for cardiovascular disease, malignancies, liver disease, and other comorbidities.